Rodríguez-Fernández Ana, Sánchez-Domínguez Marcos, Noguerado-Mellado Blanca, Rojas-Pérez-Ezquerra Patricia
Allergy Department, Hospital General Universitario Gregorio Maranon, Madrid, Spain.
Recent Pat Inflamm Allergy Drug Discov. 2019;13(1):69-72. doi: 10.2174/1872213X12666180926115034.
Paracetamol is a Non-Steroidal Anti-Inflammatory Drug (NSAID) that can produce hypersensitive reactions mediated by specific immunological mechanisms (IgE or T celldependent) or by a non-immunological mechanism (inhibition of cyclooxygenase COX-1).
An 80-year-old man with a history of allergy to pyrazolones, with good tolerance to other NSAIDs was referred to our allergy department because he presented a generalized urticaria after the administration of Intravenous (IV) paracetamol.
We performed an Intradermal Test (IDT) with paracetamol (0.02mg/ml) and later a Single Blind Oral Challenge Test (SBOCT) with oral paracetamol.
IDT reading at 15min showed negative result so an SBOCT was performed with oral paracetamol. With an accumulative dose of 250mg, after 20min, he developed discomfort, nausea and dizziness, urticarial, hypotension (BP 80/40) as well as flare-up phenomenon was observed in the site of the IDT with paracetamol. Tryptase levels during the reaction and 2hrs later were increased.
We present an anaphylactic shock due to sensitization to paracetamol because of a type I hypersensitivity mechanism, diagnosed by SBOCT and a positive IDT because of flare-up phenomenon, in a patient with previous pyrazolones allergy and with tolerance to other NSAIDs. Some relevant patents are also summarized in this paper.
对乙酰氨基酚是一种非甾体抗炎药(NSAID),可通过特定免疫机制(IgE或T细胞依赖性)或非免疫机制(抑制环氧化酶COX-1)产生过敏反应。
一名80岁男性,有吡唑酮类过敏史,对其他NSAIDs耐受性良好,因静脉注射对乙酰氨基酚后出现全身性荨麻疹,被转诊至我们的过敏科。
我们用对乙酰氨基酚(0.02mg/ml)进行皮内试验(IDT),随后用口服对乙酰氨基酚进行单盲口服激发试验(SBOCT)。
15分钟时的IDT读数显示为阴性结果,因此用口服对乙酰氨基酚进行SBOCT。累积剂量达到250mg后,20分钟时,他出现不适、恶心、头晕、荨麻疹,血压降低(80/40),并且在对乙酰氨基酚IDT部位观察到 flare-up现象。反应期间及2小时后的类胰蛋白酶水平升高。
我们报告了一名既往有吡唑酮类过敏且对其他NSAIDs耐受的患者,因I型超敏反应机制对乙酰氨基酚致敏而发生过敏性休克,通过SBOCT及因flare-up现象导致的阳性IDT确诊。本文还总结了一些相关专利。